Insider · CIK 0001217456
H Stewart Parker
Files at SGMOQ (SANGAMO THERAPEUTICS, INC), CDXS (CODEXIS, INC.). First filing -, latest -.
H Stewart Parker files SEC Form 4 as director at SGMOQ (SANGAMO THERAPEUTICS, INC), and also at CDXS (CODEXIS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; H Stewart Parker has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | CDXS CODEXIS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +66,350 | $0.00 | $0 | 66,350 | Jun 18, 2026 |
| Jun 12, 2025 | SGMOQ SANGAMO THERAPEUTICS, INC | AGrant or award Common Stock | +25,000 | $0.00 | $0 | 112,600 | Jun 16, 2025 |
| Jun 12, 2025 | SGMOQ SANGAMO THERAPEUTICS, INC | AGrant or award Stock Option (Right to Buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Jun 16, 2025 |
| Jun 10, 2025 | CDXS CODEXIS, INC. | AGrant or award Common Stock | +40,983 | $0.00 | $0 | 143,583 | Jun 12, 2025 |
Questions about H Stewart Parker
Answered from the filings on this page, as of the latest one.
Is H Stewart Parker buying or selling?
H Stewart Parker has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did H Stewart Parker's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and H Stewart Parker has 0.
Where does H Stewart Parker file Form 4?
H Stewart Parker has filed Form 4 at SGMOQ (SANGAMO THERAPEUTICS, INC); CDXS (CODEXIS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.